Skip to content
Technology

How a medicine is delivered matters.

We develop pharmaceutical formulations and drug-delivery technologies, then evaluate how they perform through analytical testing and clinical research.

Why drug delivery matters

Advancing drug-delivery science.

Three stages determine how much of an active ingredient a patient’s body can actually use. Our formulation work explores the challenges at each stage and potential approaches to addressing them.

01

Dissolution

The release and solubilisation of an active ingredient from its dosage form, enabling subsequent absorption.
02

Absorption

The process by which an active pharmaceutical ingredient crosses biological membranes and enters the body’s circulation.
03

Bioavailability

The proportion of an administered dose that reaches systemic circulation, where it becomes available to exert its therapeutic effect.
Our pathway

From formulation to evidence.

  1. 01

    Formulation development

  2. 02

    Scientific evaluation

  3. 03

    Clinical research

  4. 04

    Evidence generation

Clinical evaluation

Building evidence through clinical research.

Structured scientific and clinical evaluation is central to pharmaceutical development. A progressive approach helps us understand performance and support future clinical and regulatory pathways.

  1. 01

    Real-world evidence

    Structured observation of outcomes in everyday clinical practice.
  2. 02

    Pharmacokinetic & bioavailability studies

    Measuring how a medicine is absorbed, distributed and cleared.
  3. 03

    Clinical trials

    Controlled studies, undertaken where appropriate.
Two researchers reviewing data on a tablet in a laboratory
Collaboration

Working together to advance research.

We value engagement with scientific researchers, healthcare professionals and research organisations. Combining scientific expertise with clinical insight creates opportunities for meaningful research.